Tanabe Pharma America, Inc., the wholly owned subsidiary of Tanabe Pharma Corporation, today announced positive topline efficacy and safety results from the global Phase 3 clinical trial, also known ...
Discover four key identity and access priorities for the new year to strengthen your organization's identity security ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback